C. Morbieu
发表
J. Boffa,
I. Brochériou,
P. Michel,
2016,
Nephrologie & therapeutique.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
Gabriela K. Fragiadakis,
2022,
Science immunology.
L. Garçon,
B. Funalot,
I. Radford‐Weiss,
2022,
American journal of hematology.
N. Roche,
L. Mouthon,
I. Fajac,
2021,
American journal of respiratory and critical care medicine.
E. Vicaut,
M. Dougados,
M. Humbert,
2021,
The Lancet Respiratory Medicine.
L. Mouthon,
A. Brézin,
C. Poyart,
2022,
Ocular immunology and inflammation.
Nicolas Carlier,
Aurélien Corneau,
Nicolas Roche,
2020,
Science.
Y. Yazdanpanah,
J. Timsit,
B. Mourvillier,
2016,
Critical Care.
Paul P. Tallon,
Stéphane Huot,
B. Souweine,
2016,
Annals of Intensive Care.
P. Ravaud,
N. Roche,
J. Pawlotsky,
2020,
BMJ.
M. Michel,
O. Wagner-Ballon,
N. Limal,
2019,
Annals of Hematology.
E. Vicaut,
M. Dougados,
M. Humbert,
2021,
The Lancet Rheumatology.
L. Mouthon,
I. Fajac,
A. Dinh-Xuan,
2022,
Journal of personalized medicine.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
M. Michel,
D. Gobert,
T. Huscenot,
2018,
Blood.
F. Rieux-Laucat,
S. Kernéis,
D. Duffy,
2020,
medRxiv.
F. Maurier,
B. Pigneur,
F. Aubin,
2021,
Rheumatology.
F. Brunetti,
P. Bierling,
M. Michel,
2018,
American journal of hematology.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
P. Ravaud,
N. Roche,
L. Mouthon,
2020,
medRxiv.
F. Rieux-Laucat,
L. Chatenoud,
O. Schwartz,
2022,
Annals of the Rheumatic Diseases.
F. Rieux-Laucat,
L. Chatenoud,
O. Schwartz,
2021,
medRxiv.
N. Roche,
L. Mouthon,
N. Costedoat-Chalumeau,
2020
.
V. Sobanski,
C. Morbieu,
G. Rollin,
2019,
La Revue de medecine interne.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
P. Gregersen,
2022,
Science Immunology.
Y. Yazdanpanah,
H. Auge,
S. Diamantis,
2020,
Clinical Microbiology and Infection.